Identification of potential therapeutic targets in hypertension-associated bladder dysfunction

Area of Science:

• Cardiovascular Research
• Urology
• Molecular Biology

Background:

• Hypertension is linked to bladder dysfunction, but the underlying molecular mechanisms are not fully understood.
• Spontaneously hypertensive rats (SHRs) serve as a model to study hypertension-related physiological changes.

Purpose of the Study:

• To investigate differential gene expression in the bladder of SHRs compared to normotensive Wistar-Kyoto (WKY) rats.
• To explore the potential role of G-protein signaling pathways in hypertension-associated bladder dysfunction.

Main Methods:

• Gene expression profiling using microarray analysis in SHRs and WKY rats.
• Validation of candidate gene expression using real-time reverse transcription-polymerase chain reaction (RT-PCR).
• Assessment of voiding patterns and the effects of doxazosin and nifedipine treatment.

Main Results:

• SHRs exhibited increased voiding frequency and decreased voided volume compared to WKY rats.
• Microarray analysis identified differential expression of genes involved in G-protein signaling, calcium handling, ion transport, and smooth muscle function in SHRs.
• RT-PCR confirmed altered expression of specific genes, including those in the G-protein signaling pathway, in SHRs.
• Doxazosin treatment attenuated the observed micturition pattern and gene expression alterations in SHRs, while nifedipine did not.

Conclusions:

• Differential gene expression in G(s), G(q), and G(12/13) signaling pathways in the SHR bladder is implicated in hypertension-associated bladder dysfunction.
• These findings highlight the potential involvement of specific G-protein signaling pathways in the pathophysiology of bladder dysfunction during hypertension.